Cytosorbents Corp
CTSO
51 hedge funds and large institutions have $6.04M invested in Cytosorbents Corp in 2026 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
2% more funds holding
Funds holding: 50 → 51 (+1)
0.55% less ownership
Funds ownership: 26.23% → 25.68% (-0.55%)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
35% less capital invested
Capital invested by funds: $9.32M → $6.04M (-$3.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$151K |
| 2 |
VF
Virtu Financial
New York
|
+$37.8K |
| 3 |
Jane Street
New York
|
+$27.6K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$18K |
| 5 |
LPL Financial
San Diego,
California
|
+$14.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$262K |
| 2 |
BlackRock
New York
|
-$82.3K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$55.6K |
| 4 |
WA
Waverly Advisors
Birmingham,
Alabama
|
-$31.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
CTSO Hedge Fund Activity: Q2 2026 in Review
51 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2026, worth a combined $6.04M — down 35% from $9.32M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CTSO positions and 7 closed out — a net gain of 1 holder — while 11 added to existing stakes and 13 trimmed.
The largest buyer was Neuberger Berman Group, adding an estimated $151K. The largest seller was Skylands Capital, cutting an estimated $262K.
- 51 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2026, up from 50 in Q1 2026.
- Funds reported $6.04M of Cytosorbents Corp stock for Q2 2026, down 35% quarter-over-quarter.
- 8 funds opened new Cytosorbents Corp positions in Q2 2026 and 7 closed out, a net change of +1 holder.
- The largest Cytosorbents Corp buyer in Q2 2026 was Neuberger Berman Group, an estimated $151K added.
- The largest Cytosorbents Corp seller in Q2 2026 was Skylands Capital, an estimated $262K sold.
Based on aggregated 13F filings for Q2 2026.